Fuji expands its cell manufacturing in U.S. and U.K.

Fujifilm Diosynth Biotechnologies is adding a 2000-L single-use bioreactor at its plants in Research Triangle Park, NC, in the U.S. and Billingham in the U.K. to expand its cell culture manufacturing. "Having identical single-use operations on both sides of the Atlantic offers our customers flexibility and easy access to global markets," Steve Bagshaw, CEO of the operation, said today. Fujifilm just last year added the mammalian cell culture cGMP manufacturing facility in Billingham. Release | More